These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
598 related items for PubMed ID: 14748278
1. [Intratympanic gentamicin treatment for intractable Menière's disease]. Gilony D, Wolf M, Kronenberg J. Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278 [Abstract] [Full Text] [Related]
2. Intratympanic gentamicin for intractable Meniere's disease. Perez N, Martín E, García-Tapia R. Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197 [Abstract] [Full Text] [Related]
3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Wu IC, Minor LB. Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316 [Abstract] [Full Text] [Related]
4. Intratympanic gentamicin injection for the treatment of Meniere's disease. Youssef TF, Poe DS. Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751 [Abstract] [Full Text] [Related]
5. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss. Derebery MJ, Fisher LM, Berliner K, Chung J, Green K. Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498 [Abstract] [Full Text] [Related]
6. Treatment of Ménière's disease by intratympanic gentamicin application. Assimakopoulos D, Patrikakos G. J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850 [Abstract] [Full Text] [Related]
7. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease. Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T. Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414 [Abstract] [Full Text] [Related]
8. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes. Smith WK, Sandooram D, Prinsley PR. J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921 [Abstract] [Full Text] [Related]
9. Intratympanic gentamicin therapy for intractable Ménière's disease. De Beer L, Stokroos R, Kingma H. Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229 [Abstract] [Full Text] [Related]
10. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing. Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA. Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280 [Abstract] [Full Text] [Related]
11. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin. Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N. Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149 [Abstract] [Full Text] [Related]
12. Hearing results following intratympanic gentamicin perfusion for Ménière's disease. Kyrodimos E, Aidonis I, Sismanis A. J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493 [Abstract] [Full Text] [Related]
13. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing]. Akkuzu B, Ozgirgin N, Ozlüoğlu LN. Kulak Burun Bogaz Ihtis Derg; 2006 Apr; 16(5):193-9. PubMed ID: 17124437 [Abstract] [Full Text] [Related]